Metropolitan Life Insurance Company (MetLife)’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,164
| Closed | -$68.9K | – | 750 |
|
|
2024
Q1 | $68.9K | Sell |
2,164
-448
| -17% | -$14.3K | ﹤0.01% | 1249 |
|
|
2023
Q4 | $52.9K | Hold |
2,612
| – | – | ﹤0.01% | 1421 |
|
|
2023
Q3 | $33.3K | Buy |
2,612
+850
| +48% | +$10.8K | ﹤0.01% | 1623 |
|
|
2023
Q2 | $31.8K | Hold |
1,762
| – | – | ﹤0.01% | 1682 |
|
|
2023
Q1 | $30.3K | Sell |
1,762
-325
| -16% | -$5.59K | ﹤0.01% | 1679 |
|
|
2022
Q4 | $46.4K | Hold |
2,087
| – | – | ﹤0.01% | 1520 |
|
|
2022
Q3 | $16.8K | Hold |
2,087
| – | – | ﹤0.01% | 2107 |
|
|
2022
Q2 | $14.6K | Hold |
2,087
| – | – | ﹤0.01% | 2198 |
|
|
2022
Q1 | $31.6K | Sell |
2,087
-6,197
| -75% | -$93.7K | ﹤0.01% | 1855 |
|
|
2021
Q4 | $182K | Buy |
8,284
+2,247
| +37% | +$49.3K | ﹤0.01% | 2092 |
|
|
2021
Q3 | $163K | Buy |
+6,037
| New | +$163K | ﹤0.01% | 2235 |
|
|
2021
Q2 | – | Sell |
-2,984
| Closed | -$129K | – | 2762 |
|
|
2021
Q1 | $129K | Buy |
+2,984
| New | +$129K | ﹤0.01% | 2305 |
|